176 related articles for article (PubMed ID: 26154815)
21. The relationship between cannabis use and schizotypal symptoms.
Bailey EL; Swallow BL
Eur Psychiatry; 2004 Apr; 19(2):113-4. PubMed ID: 15051110
[TBL] [Abstract][Full Text] [Related]
22. Patterns of cannabis use, psychotic-like experiences and personality styles in young cannabis users.
Spriggens L; Hides L
Schizophr Res; 2015 Jun; 165(1):3-8. PubMed ID: 25868934
[TBL] [Abstract][Full Text] [Related]
23. [Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder].
Kazour F; Awaida C; Souaiby L; Richa S
Encephale; 2018 Feb; 44(1):14-21. PubMed ID: 27745717
[TBL] [Abstract][Full Text] [Related]
24. Associations between past alcohol, cannabis, and cocaine use and current schizotypy among first-degree relatives of patients with schizophrenia and non-psychiatric controls.
Compton MT; Chien VH; Bollini AM
Psychiatr Q; 2009 Sep; 80(3):143-54. PubMed ID: 19396546
[TBL] [Abstract][Full Text] [Related]
25. Positive and negative schizotypy are associated with prodromal and schizophrenia-spectrum symptoms.
Barrantes-Vidal N; Gross GM; Sheinbaum T; Mitjavila M; Ballespí S; Kwapil TR
Schizophr Res; 2013 Apr; 145(1-3):50-5. PubMed ID: 23402694
[TBL] [Abstract][Full Text] [Related]
26. Combining trait and state model systems of psychosis: The effect of sleep deprivation on cognitive functions in schizotypal individuals.
Faiola E; Meyhöfer I; Steffens M; Kasparbauer AM; Kumari V; Ettinger U
Psychiatry Res; 2018 Dec; 270():639-648. PubMed ID: 30384284
[TBL] [Abstract][Full Text] [Related]
27. Predicting creativity: the role of psychometric schizotypy and cannabis use in divergent thinking.
Minor KS; Firmin RL; Bonfils KA; Chun CA; Buckner JD; Cohen AS
Psychiatry Res; 2014 Dec; 220(1-2):205-10. PubMed ID: 25219611
[TBL] [Abstract][Full Text] [Related]
28. Polydrug use, cannabis, and psychosis-like symptoms.
Van Dam NT; Earleywine M; DiGiacomo G
Hum Psychopharmacol; 2008 Aug; 23(6):475-85. PubMed ID: 18449850
[TBL] [Abstract][Full Text] [Related]
29. Schizotypal traits and cognitive performance in siblings of patients with psychosis.
Moreno-Samaniego L; Gaviria AM; Vilella E; Valero J; Labad A
Psychiatry Res; 2017 Dec; 258():551-556. PubMed ID: 28958455
[TBL] [Abstract][Full Text] [Related]
30. Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample.
Barkus E; Lewis S
Psychol Med; 2008 Sep; 38(9):1267-76. PubMed ID: 18205966
[TBL] [Abstract][Full Text] [Related]
31. Cognitive profiles of schizotypal dimensions in a community cohort: Common properties of differential manifestations.
Karagiannopoulou L; Karamaouna P; Zouraraki C; Roussos P; Bitsios P; Giakoumaki SG
J Clin Exp Neuropsychol; 2016 Nov; 38(9):1050-63. PubMed ID: 27295077
[TBL] [Abstract][Full Text] [Related]
32. Hemispheric language asymmetry in first episode psychosis and schizotypy: the role of cannabis consumption and cognitive disorganization.
Herzig DA; Sullivan S; Lewis G; Corcoran R; Drake R; Evans J; Nutt D; Mohr C
Schizophr Bull; 2015 Mar; 41 Suppl 2(Suppl 2):S455-64. PubMed ID: 25543118
[TBL] [Abstract][Full Text] [Related]
33. Psychometric schizotypy predicts psychotic-like, paranoid, and negative symptoms in daily life.
Barrantes-Vidal N; Chun CA; Myin-Germeys I; Kwapil TR
J Abnorm Psychol; 2013 Nov; 122(4):1077-87. PubMed ID: 24364610
[TBL] [Abstract][Full Text] [Related]
34. Cannabis-induced psychosis-like experiences are associated with high schizotypy.
Barkus EJ; Stirling J; Hopkins RS; Lewis S
Psychopathology; 2006; 39(4):175-8. PubMed ID: 16636640
[TBL] [Abstract][Full Text] [Related]
35. The impact of cannabis and stimulant disorders on diagnostic stability in psychosis.
Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
J Clin Psychiatry; 2014 Apr; 75(4):349-56. PubMed ID: 24813404
[TBL] [Abstract][Full Text] [Related]
36. Follow-up factor structure of schizotypy and its clinical associations in a help-seeking sample meeting ultra-high risk for psychosis criteria at baseline.
Lin A; Wigman JT; Nelson B; Wood SJ; Vollebergh WA; van Os J; Yung AR
Compr Psychiatry; 2013 Feb; 54(2):173-80. PubMed ID: 22901838
[TBL] [Abstract][Full Text] [Related]
37. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
38. Stress and cognitive biases in schizotypy: A two-site study of bias against disconfirmatory evidence and jumping to conclusions.
Le TP; Fedechko TL; Cohen AS; Allred S; Pham C; Lewis S; Barkus E
Eur Psychiatry; 2019 Oct; 62():20-27. PubMed ID: 31509790
[TBL] [Abstract][Full Text] [Related]
39. Relationship between drug use and psychopathological variables of risk in university students.
García Montes JM; Zaldívar Basurto F; Moreno Montoya M; Flores Cubos P
Psicothema; 2013; 25(4):433-9. PubMed ID: 24124774
[TBL] [Abstract][Full Text] [Related]
40. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD).
Hollis C; Groom MJ; Das D; Calton T; Bates AT; Andrews HK; Jackson GM; Liddle PF
Schizophr Res; 2008 Oct; 105(1-3):216-23. PubMed ID: 18768298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
